Sort
30,917 grants matching “tumor microenvironment”
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$529,313Andre Elias Nel · University Of California Los Angeles · R01 · FY2022 · CA
Integration of Actin Dynamics and Adhesion in Cell Migration
$529,301Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str
$529,299Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$529,280Bryan Quilty Spring · Northeastern University · U01 · FY2023 · CA
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
$529,244Simone Krebs · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Targeting Hippo pathway in melanoma
$529,237Xu Wu · Massachusetts General Hospital · R01 · FY2020 · CA
Targeting Hippo pathway in melanoma
$529,237Xu Wu · Massachusetts General Hospital · R01 · FY2021 · CA
Targeting Hippo pathway in melanoma
$529,237Xu Wu · Massachusetts General Hospital · R01 · FY2019 · CA
Molecular Drivers and Therapeutic Susceptibilities in Neuroendocrine Prostate Cancer
$529,166Felix Yi-Chung Feng · University Of Wisconsin-Madison · P01 · FY2025 · CA
Small molecule CXCR4 modulators as molecular probes for studying AML
$529,121Gary E Schiltz · Northwestern University · R01 · FY2015 · CA
Role of the stromal microenvironment in B-cell lymphoma progression and immune escape
$529,121Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
$529,039Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
The role of collagen and its signaling mechanisms in glioma progression and invasion.
$529,012Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Tumor immune and glycan biomarkers for progressive prostate cancer
$529,005Jennifer D Wu · Northwestern University At Chicago · R01 · FY2020 · CA
Interrogating Type I Interferon signaling in breast cancer brain metastasis
$529,002Qing Chen · Wistar Institute · R01 · FY2024 · CA
Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications
$528,946Irving C Allen · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · CA
Improving the translational value of head and neck cancer patient-in-mouse models
$528,946Randall J Kimple · University Of Wisconsin-Madison · R37 · FY2022 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$528,929Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$528,929Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Dynamic Optical Imaging Biomarkers of Tumor Response to Therapy
$528,877Stefan Alexandru Carp · Massachusetts General Hospital · R01 · FY2016 · CA
Isolation, Propagation and Characterization of Breast Stem Cells
$528,628Barbara Vonderhaar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia
$528,622Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2025 · CA
Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia
$528,622Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2021 · CA
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors
$528,617Yao Liang Tang · Augusta University · R01 · FY2018 · AR
T-cell plasticity mediating treatment resistance and side effects in atopic dermatitis
$528,558Patrick Brunner · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AR